Ethnicity and COVID-19: investigating the determinants of excess risk in UK Biobank

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:25 publications

Grant number: MR/V020536/1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $84,482.93
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Professor Thomas Yates
  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Leicester
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease susceptibility

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

What is the problem? People from minority ethnic groups seem to be disproportionally affected by COVID-19, particularly South Asian and Black and African Caribbean communities. What has been done so far? National datasets have shown that minority ethnic groups are up to 4 times more likely to die from COVID-19. However, the reason for this increased risk is not known. What are we going to do? We will use a large dataset, called UK Biobank, which has been linked to national COVID-19 data. Within this dataset, we will use statistical modelling to examine whether the increased risk in minority ethnic groups is explained by differences in underlying health status, lifestyle behaviours such as physical activity, and environmental factors such as air pollution or measures of social inequality. Why is this important? This work will start to unpick why minority ethnic groups may be at increased risk and whether this increased risk is spread equality across the population. For example, is the increased risk explained by a higher burden of other diseases such as heart disease or diabetes or by living in more polluted areas? Do otherwise healthy individuals from minority ethnic groups still have an increased risk? Addressing these question will help inform public health priorities and actions.

Publicationslinked via Europe PMC

COVID-19 vaccination uptake amongst ethnic minority communities in England: a linked study exploring the drivers of differential vaccination rates.

Remission of type 2 diabetes and improved diastolic function by combining structured exercise with meal replacement and food reintroduction among young adults: the RESET for REMISSION randomised controlled trial protocol.

Self-reported walking pace, polygenic risk scores and risk of coronary artery disease in UK biobank.

Device-assessed sleep and physical activity in individuals recovering from a hospital admission for COVID-19: a multicentre study.

Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19.

Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study.

Admission Blood Glucose Level and Its Association With Cardiovascular and Renal Complications in Patients Hospitalized With COVID-19.

A population-based cohort study of obesity, ethnicity and COVID-19 mortality in 12.6 million adults in England.

Monitoring sociodemographic inequality in COVID-19 vaccination uptake in England: a national linked data study.